| 000 | 01667 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515091922.0 | ||
| 264 | 0 | _c20080208 | |
| 008 | 200802s 0 0 eng d | ||
| 022 | _a0085-2538 | ||
| 024 | 7 |
_a10.1038/sj.ki.5002628 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFervenza, F C | |
| 245 | 0 | 0 |
_aRituximab treatment of idiopathic membranous nephropathy. _h[electronic resource] |
| 260 |
_bKidney international _cJan 2008 |
||
| 300 |
_a117-25 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 |
_aB-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlomerulonephritis, Membranous _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins _xblood |
| 650 | 0 | 4 |
_aImmunologic Factors _xadverse effects |
| 650 | 0 | 4 | _aLymphocyte Count |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 |
_aProteinuria _xdiagnosis |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aCosio, F G | |
| 700 | 1 | _aErickson, S B | |
| 700 | 1 | _aSpecks, U | |
| 700 | 1 | _aHerzenberg, A M | |
| 700 | 1 | _aDillon, J J | |
| 700 | 1 | _aLeung, N | |
| 700 | 1 | _aCohen, I M | |
| 700 | 1 | _aWochos, D N | |
| 700 | 1 | _aBergstralh, E | |
| 700 | 1 | _aHladunewich, M | |
| 700 | 1 | _aCattran, D C | |
| 773 | 0 |
_tKidney international _gvol. 73 _gno. 1 _gp. 117-25 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.ki.5002628 _zAvailable from publisher's website |
| 999 |
_c17463319 _d17463319 |
||